PUBLICACIÓN

    A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms

    Listado de proyectos

    • Fecha de inicio: 09.12.2009

    Investigadores

    ETIQUETAS

    • Journal Publications

    COMPARTE

    Segales, J; Urniza, A; Alegre, A; Bru, T; Crisci, E; Nofrarias, M; Lopez-Soria, S; Balasch, M; Sibila, M; Xu, Z; Chu, H -J; Fraile, L; Plana-Duran, J (2009). A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine, 27(52), 7313-7321. DOI: 10.1016/j.vaccine.2009.09.084

    Investigadores

    This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.